SCHEMBL8957335

SCHEMBL8957335

COc1ccc(OCCO[N+](=O)[O-])cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
KMT2A Q03164 2/20 0.58
CA12 O43570 3/20 0.53
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CA4 P22748 3/20 0.53
CA9 Q16790 3/20 0.53
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
LMNA P02545 3/20 0.49
POLB P06746 1/20 0.49
FBP1 P09467 1/20 0.47
MAPT P10636 3/20 0.46
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 1/20 0.43
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803032 0.81 CA12 (0.53) SMN1; SMN2NPC1RAB9AKMT2ACA12
SCHEMBL8957299 0.81 MAPT (0.56) KMT2ACA12CA1CA2CA4
SCHEMBL8957416 0.81 CA12 (0.53) SMN1; SMN2NPC1RAB9AKMT2ACA12
SCHEMBL8957342 0.81 KCNA3 (0.52) SMN1; SMN2NPC1RAB9AKMT2ACA12
SCHEMBL1343630 0.79 CA12 (0.65) SMN1; SMN2NPC1RAB9ACA12CA1
SCHEMBL7364250 0.79 ALDH1A1 (0.50) SMN1; SMN2RAB9AKMT2ACA12CA1
SCHEMBL11004696 0.78 TUBB4A (0.50) SMN1; SMN2NPC1RAB9AKMT2ACA12
SCHEMBL2801843 0.78 CA12 (0.49) SMN1; SMN2NPC1RAB9AKMT2ACA12
SCHEMBL8957360 0.77 CALM1 (0.50) NPC1RAB9ACA12CA1CA2
SCHEMBL8957481 0.77 PKM (0.64) CA12CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP disclosed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO disclosed